BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21082265)

  • 1. The enhancement of propyl gallate-induced HeLa cell death by MAPK inhibitors is accompanied by increasing ROS levels.
    You BR; Park WH
    Mol Biol Rep; 2011 Apr; 38(4):2349-58. PubMed ID: 21082265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
    Park WH
    Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
    Park WH
    Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-apoptotic effects of caspase inhibitors on propyl gallate-treated HeLa cells in relation to reactive oxygen species and glutathione levels.
    Han YH; Moon HJ; You BR; Park WH
    Arch Toxicol; 2009 Sep; 83(9):825-33. PubMed ID: 19434396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132.
    You BR; Park WH
    Oncol Rep; 2011 Mar; 25(3):871-7. PubMed ID: 21186403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level.
    Han YH; Park WH
    Food Chem Toxicol; 2009 Oct; 47(10):2531-8. PubMed ID: 19622380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    Han YH; Park WH
    Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propyl gallate inhibits the growth of endothelial cells, especially calf pulmonary arterial endothelial cells via caspase-independent apoptosis.
    Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Jun; 25(6):937-44. PubMed ID: 20428799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of propyl gallate-induced calf pulmonary arterial endothelial cell death by MEK and JNK inhibitors.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2009; 2(5):825-30. PubMed ID: 21475908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propyl gallate inhibits the growth of calf pulmonary arterial endothelial cells via glutathione depletion.
    Han YH; Moon HJ; You BR; Park WH
    Toxicol In Vitro; 2010 Jun; 24(4):1183-9. PubMed ID: 20159035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
    You BR; Park WH
    Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Anti-Apoptotic Effects of Caspase Inhibitors in Propyl Gallate-Treated Lung Cancer Cells Are Related to Changes in Reactive Oxygen Species and Glutathione Levels.
    Park WH
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
    Han YH; Park WH
    Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2009 Nov; 24(5):717-22. PubMed ID: 19787207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.